New Drugs for Children in the Food and Drug Administration Pipeline

Marcia L. Buck, PharmD, FCCP, FPPAG

Disclosures

Pediatr Pharm. 2015;21(2) 

In This Article

Introduction

Several drugs in development have the potential to benefit children. New Drug Applications (NDA) and preliminary filings with the Food and Drug Administration (FDA) in the past 4 months include a new antiepileptic, several long-awaited drugs for the treatment of Duchenne muscular dystrophy, a chemotherapeutic agent for neuroblastoma, a CFTR corrector to be used in combination with ivacaftor in patients with cystic fibrosis, and a monoclonal antibody for patients with severe eosinophilic asthma.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....